Anesthesiology: Perioperative medicine or "when the anesthetic is a diuretic"

Journal of Clinical Anesthesia

Volumn 16, Issue 2, 2004, Pages 130-137

  White, Sno E ^a   Morey, Timothy E ^b   Yeager, Anita ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Anesthesiology ^*  (United States)

Author keywords

Congestive heart disease; Diastolic dysfunction; Diuretics; Dyspnea

Indexed keywords

ANESTHETIC AGENT; DIGOXIN; DIURETIC AGENT; FUROSEMIDE; MORPHINE;

AGE; AGED; ANAMNESIS; ANESTHESIOLOGY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOSE RESPONSE; FEMALE; HUMAN; KINESIOTHERAPY; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PHYSICIAN; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANESTHETICS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; DIGOXIN; DIURETICS; FEMALE; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HUMANS; MALE;

EID: 2142751580     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2003.08.003     Document Type: Conference Paper

References (69)

1. Massie B.M., Shah N.B. Evolving trends in the epidemiologic factors of heart failure rationale for preventive strategies and comprehensive disease management. Am Heart J. 133:1997;703-712.
2. Schrier R.W., Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med. 341:1999;577-585.
3. Mann D.L., Kent R.L., Parsons B., Cooper G. 4th. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804.
4. Tan L.B., Jalil J.E., Pick R., Janicki J.S., Weber K.T. Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 69:1991;1185-1195.
5. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865.
6. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 98:1998;1329-1334.
7. Eichhorn E.J., Bristow M.R. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 94:1996;2285-2296.
8. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., Eichhorn E.J. Time course of improvement in left ventricular function, mass, and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161.
9. Greenberg B., Quinones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 91:1995;2573-2581.
10. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 327:1992;669-677.
11. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 273:1995;1450-1456.
12. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302
13. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
14. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355(9200):253-9
15. Consensus recommendations for the management of heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 1999;83:1A-38A
16. Ellison D.H. The physiologic basis of diuretic synergism its role in treating diuretic resistance. An Intern Med. 114:1991;886-894.
17. Brater D.C. Diuretic therapy. N Engl J Med. 339:1998;387-395.
18. Vantrimpont P., Rouleau J.L., Wun C.C., et al. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol. 29:1997;229-236.
19. Hjalmarson A., Goldstein S., Fagerberg B. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group. JAMA. 283:2000;1295-1302.
20. Lechat P., Packer M., Chalon S., Cucherat M., Arab T., Boissel J.P. Clinical effects of beta-adrenergic blockade in chronic heart failure a meta-analysis of double blind, placebo-controlled, randomized trials. Circulation. 98:1998;1184-1191.
21. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353(9169):2001-7
22. The effect of digoxin on mortality and morbidity in patients with heart failure. Digitalis Investigation Group. N Engl J Med 1997;336:525-33
23. Uretsky B.F., Young J.B., Shahidi F.E., Yellen L.G., Harrison M.C., Jolly M.K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 22:1993;955-962.
24. Packer M., Gheorghiade M., Young J.B., et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med. 329:1993;1-7.
25. Gheorghiade M., Ferguson D. Digoxin. A neurohormonal modulator in heart failure? Circulation. 84:1991;2181-2186.
26. Mason D.T., Braunwald E. Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients in heart failure. J Clin Invest. 43:1964;532-543.
27. van Veldhuisen D.J., Man in't Veld A.J., Dunselman P.H., et al. Double-blind, placebo controlled study of ibopamine and digoxin in patients with mild to moderate heart failure results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol. 22:1993;1564-1573.
28. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis inpatients with chronic congestive heart failure. N Engl J Med. 311:1984;819-823.
29. Gheorghiade M., Hall V.B., Jacobsen G., Alam M., Rosman H., Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patient with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation. 92:1995;1801-1807.
30. Slatton M.L., Irani W.N., Hall S.A., et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol. 29:1997;1206-1213.
31. Packer M. Hemodynamic consequences of antiarrhythmic drug therapy in patients with chronic heart failure. J Cardiovasc Electrophysiol. 2:(Suppl):1991;S240-247.
32. Heerdink E.R., Leufkens H.G., Herings R.M., Ottervanger J.P., Stricker B.H., Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 158:1998;1108-1112.
33. Packer M., Kessler P.D., Lee W.H. Calcium-channel blockade in the management of severe chronic congestive heart failure a bridge too far. Circulation. 75:(6 Pt 2):1987;V56-64.
34. Tresch D.D. The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc. 45:1997;1128-1133.
35. Rockwood K. Acute confusion in elderly medical patients. J Am Geriatr Soc. 37:1989;150-154.
36. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 33:1999;1948-1955.
37. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly the Cardiovascular Health Study. J Am Coll Cardiol. 35:2000;1628-1637.
38. Bulpitt C.J., Rajkumar C., Cameron J.D. Vascular compliance as a measure of biological age. J Am Geriatr Soc. 47:1999;657-663.
39. Olson L.J., Gertz M.A., Edwards W.D., et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med. 317:1987;738-742.
40. Cody R.J. The treatment of diastolic heart failure. Cardiol Clin. 18:2000;589-596.
41. Downes T.R., Nomeir A.M., Smith K.M., Stewart K.P., Little W.C. Mechanism of altered pattern of left ventricular filling with aging in subjects without cardiac disease. Am J Cardiol. 64:1989;523-527.
42. Oren S., Grossman E., Frohlich E.D. Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril. Am J Cardiol. 77:1996;93-96.
43. Aronow W.S., Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol. 71:1993;602-604.
44. Philbin E.F., Rocco T.A. Jr. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J. 134:(2 Pt 1):1997;188-195.
45. Cheng C.P., Igarashi Y., Little W.C. Mechanism of augmented rate of left ventricular filling during exercise. Circ Res. 70:1992;9-19.
46. Ogawa T., Spina R.J., Martin W.H. 3rd, et al. Effect of aging, sex, and physical training on cardiovascular responses to exercise. Circulation. 86:1992;494-503.
47. Levy W.C., Cerqueira M.D., Abrass I.B., Schwartz R.S., Stratton R.J. Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men. Circulation. 88:1993;116-126.
48. Sullivan M.J., Higginbotham M.B., Cobb F.R. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation. 78:1988;506-515.
49. Coats A.J., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 85:1992;2119-2131.
50. Belardinelli R., Georgiou D., Cianci G., Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure effects on functional capacity, quality of life, and clinical outcome. Circulation. 99:1999;1173-1182.
51. Hambrecht R., Gielen S., Link A., et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure. A randomized trial. JAMA. 283:2000;3095-3101.
52. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 288:2002;2144-2150.
53. Gianuzzi P., Temporelli P.L., Corra U., Gattone M., Giordano A., Tavazzi L. Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction results of the Exercise in Left Ventricular Dysfunction (ELVD) Trial. Circulation. 96:1997;1790-1797.
54. Katz S.D., Yuen J., Bijou R., LeJemtel T.H. Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure. J Appl Phys. 82:1997;1488-1492.
55. Clark A.L., Poole-Wilson P.A., Coats A.J. Exercise limitation in chronic heart failure central role of the periphery. J Am Coll Cardiol. 28:1996;1092-1102.
56. Katz SD, Klapholz M, Jandeau G, Galvao M: Endothelium-dependent vasodilatation is improved by physical training in normal subjects. In: Broustet JP (ed): Proceedings of the 5th World Congress on Cardiac Rehabilitation. Andover, UK: Intercept, 1993:229-37
57. Langille B.L., O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 231:(4736):1986;405-407.
58. Beere P.A., Russell S.D., Morey M.C., Kitzman D.W., Higginbotham M.D. Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men. Circulation. 100:1999;1085-1094.
59. Belardinelli R., Georgiou D., Cianci G., Berman N., Ginzton L., Purcaro A. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications. Circulation. 91:1995;2775-2784.
60. Grossman W., McLaurin L.P., Rolett E.L. Alterations in left ventricular relaxation and diastolic compliance in congestive cardiomyopathy. Cardiovasc Res. 13:1979;514-522.
61. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 297:1977;845-850.
62. Detsky A.S., Abrams H.B., McLaughlin J.R., et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med. 1:1986;211-219.
63. American Society of Anesthesiologists I: New classification of physical status. Anesthesiology 1963;24:111
64. Fox K.F., Cowie M.R., Wood D.A., Coats A.J., Poole-Wilson P.A., Sutton G.C. A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail. 2:2000;423-429.
65. Clarke K.W., Gray D., Hampton J.R. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 71:1994;584-587.
66. Cline C.M., Bjorck-Linne A.K., Israelsson B.Y., Willenheimer R.B., Erhardt L.R. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail. 1:1999;145-149.
67. Rich M.W., Gray D.B., Beckham V., Wittenberg C., Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 101:1996;270-276.
68. Hussey L.C., Hardin S., Blanchette C. Outpatient costs of medications for patients with chronic heart failure. Am J Crit Care. 11:2002;474-478.
69. Cowie M.R., Wood D.A., Coats A.J., et al. Survival of patients with a new diagnosis of heart failure a population based study. Heart. 83:2000;505-510.